Literature DB >> 2745554

SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix.

H Sage1, R B Vernon, S E Funk, E A Everitt, J Angello.   

Abstract

SPARC (Secreted Protein Acidic and Rich in Cysteine) is a Ca+2-binding glycoprotein that is differentially associated with morphogenesis, remodeling, cellular migration, and proliferation. We show here that exogenous SPARC, added to cells in culture, was associated with profound changes in cell shape, caused rapid, partial detachment of a confluent monolayer, and inhibited spreading of newly plated cells. Bovine aortic endothelial cells, exposed to 2-40 micrograms SPARC/ml per 2 x 10(6) cells, exhibited a rounded morphology in a dose-dependent manner but remained attached to plastic or collagen-coated surfaces. These round cells synthesized protein, uniformly excluded trypan blue, and grew in aggregates after replating in media without SPARC. SPARC caused rounding of bovine endothelial cells, fibroblasts, and smooth muscle cells; however, the cell lines F9, PYS-2, and 3T3 were not affected. The activity of native SPARC was inhibited by heat denaturation and prior incubation with anti-SPARC IgG. The effect of SPARC on endothelial cells appeared to be independent of the rounding phenomenon produced by the peptide GRGDSP. Immunofluorescence localization of SPARC on endothelial cells showed preferential distribution at the leading edges of membranous extensions. SPARC bound Ca+2 in both amino- and carboxyl-terminal (EF-hand) domains and required this cation for maintenance of native structure. Solid-phase binding assays indicated a preferential affinity of native SPARC for several proteins comprising the extracellular matrix, including types III and V collagen, and thrombospondin. This binding was saturable, Ca+2 dependent, and inhibited by anti-SPARC IgG. Endothelial cells also failed to spread on a substrate of native type III collagen complexed with SPARC. We propose that SPARC is an extracellular modulator of Ca+2 and cation-sensitive proteins or proteinases, which facilitates changes in cellular shape and disengagement of cells from the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2745554      PMCID: PMC2115491          DOI: 10.1083/jcb.109.1.341

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  77 in total

1.  Colocalization of calcium-dependent protease II and one of its substrates at sites of cell adhesion.

Authors:  M C Beckerle; K Burridge; G N DeMartino; D E Croall
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

2.  The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model.

Authors:  R F Nicosia; J A Madri
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

3.  Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor.

Authors:  D A Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

4.  Platelet glycoprotein IIb-IIIa-like proteins mediate endothelial cell attachment to adhesive proteins and the extracellular matrix.

Authors:  I F Charo; L S Bekeart; D R Phillips
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

5.  Regulation of vascular smooth muscle cell growth by endothelial-synthesized extracellular matrices.

Authors:  I M Herman; J J Castellot
Journal:  Arteriosclerosis       Date:  1987 Sep-Oct

6.  Characterization of porcine osteonectin extracted from foetal calvariae.

Authors:  C Domenicucci; H A Goldberg; T Hofmann; D Isenman; S Wasi; J Sodek
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

7.  Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation.

Authors:  J E Murphy-Ullrich; D F Mosher
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

8.  The platelet glycoprotein IIb/IIIa-like protein in human endothelial cells promotes adhesion but not initial attachment to extracellular matrix.

Authors:  C S Chen; P Thiagarajan; S M Schwartz; J M Harlan; R L Heimark
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

Review 9.  Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells.

Authors:  W A Frazier
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

10.  In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization.

Authors:  P W Holland; S J Harper; J H McVey; B L Hogan
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

View more
  103 in total

1.  SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

Authors:  Barbara J Schiemann; Jason R Neil; William P Schiemann
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

2.  Matricellular homologs in the foreign body response: hevin suppresses inflammation, but hevin and SPARC together diminish angiogenesis.

Authors:  Thomas H Barker; Paul Framson; Pauli A Puolakkainen; May Reed; Sarah E Funk; E Helene Sage
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

3.  Mathematical analysis of a basic model for epidermal wound healing.

Authors:  J A Sherratt; J D Murray
Journal:  J Math Biol       Date:  1991       Impact factor: 2.259

4.  Fibroblast migration after myocardial infarction is regulated by transient SPARC expression.

Authors:  Rong Xue Wu; Martin Laser; Hong Han; Jeeva Varadarajulu; Kai Schuh; Matthias Hallhuber; Kai Hu; Georg Ertl; Christof R Hauck; Oliver Ritter
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

Review 5.  The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.

Authors:  Sharon L I Wong; Maria B Sukkar
Journal:  Br J Pharmacol       Date:  2016-11-25       Impact factor: 8.739

Review 6.  The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.

Authors:  Anguo Liu; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Microvasc Res       Date:  2008-10-01       Impact factor: 3.514

7.  Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.

Authors:  Shanna A Arnold; Lee B Rivera; Andrew F Miller; Juliet G Carbon; Sean P Dineen; Yang Xie; Diego H Castrillon; E Helene Sage; Pauli Puolakkainen; Amy D Bradshaw; Rolf A Brekken
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

8.  Conformational changes of bovine bone osteonectin induced by interaction with calcium.

Authors:  H Takita; Y Kuboki
Journal:  Calcif Tissue Int       Date:  1995-06       Impact factor: 4.333

9.  SPARC/osteonectin mRNA is induced in blood vessels following injury to the adult rat cerebral cortex.

Authors:  D B Mendis; G O Ivy; I R Brown
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

10.  SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.

Authors:  R H Pichler; J A Bassuk; C Hugo; M J Reed; E Eng; K L Gordon; J Pippin; C E Alpers; W G Couser; E H Sage; R J Johnson
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.